RemSleep Holdings Inc. Announces Acceptance and Approval of the Company’s OTCQB Application

Tampa, FL, July 12, 2022 (GLOBE NEWSWIRE) -- RemSleep Holdings Inc. (OTCPINK:RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients, announced today that the company has officially received approval to be uplisted to OTCQB® status with otcmarkets.com. We anticipate OTCQB® status to be live on otcmarkets.com within 24-48 hours of this press release. The move to the OTCQB® exchange provides enhanced investor benefits, including higher reporting standards, greater access to analyst coverage and news outlets, increased liquidity and stability, along with more comprehensive compliance requirements. The OTCQB® exchange is considered by the Securities and Exchange Commission (SEC) as an "established public market" for determining the public market price when registering securities for resale with the SEC. The OTC Pink is not considered as such, and because of this most broker dealers will not trade or recommend OTC Pink stocks. By gaining OTCQB® status, a company dramatically increases their transparency, reporting standards, and management certification and compliance requirements, therefore most broker dealers trade stocks on the OTCQB® exchange. Historically, companies that have made it to the OTCQB® tier have experienced increased investor awareness and greater liquidity and visibility of their common stock.